Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | LPL | P06858 | 2/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | PLK1 | P53350 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5305289 | 0.85 | CA2 (0.44) | CA2NPC1RAB9ATP53GPR84 | |
| SCHEMBL5286448 | 0.83 | PTGS2 (0.48) | CA2LPLLIPGTP53GPR84 | |
| SCHEMBL5293896 | 0.81 | PTGS2 (0.50) | CA2LPLLIPGMGLLTP53 | |
| SCHEMBL5292265 | 0.81 | PTGS2 (0.50) | CA2LPLLIPGMGLLTP53 | |
| SCHEMBL5288228 | 0.81 | PTGS2 (0.50) | CA2LPLLIPGMGLLTP53 | |
| SCHEMBL5307800 | 0.81 | PTGS2 (0.50) | CA2LPLLIPGMGLLTP53 | |
| SCHEMBL5293845 | 0.81 | PTGS2 (0.50) | CA2LPLLIPGMGLLTP53 | |
| SCHEMBL5298721 | 0.81 | PTGS2 (0.50) | CA2LPLLIPGMGLLTP53 | |
| SCHEMBL5290790 | 0.81 | PTGS2 (0.50) | CA2LPLLIPGMGLLTP53 | |
| SCHEMBL5299690 | 0.81 | PTGS2 (0.50) | CA2LPLLIPGMGLLTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10001703-B2 | Photopolymer formulation for production of holographic media comprising borates with low TG | COVESTRO DEUTSCHLAND AG (DE) | 2018-06-19 | — | — | US | disclosed |
| US-10001703-B2 | Photopolymer formulation for production of holographic media comprising borates with low TG | COVESTRO DEUTSCHLAND AG (DE) | 2018-06-19 | — | — | US | disclosed |
| EP-3058423-B1 | PHOTOPOLYMER FORMULATION FOR PRODUCING HOLOGRAPHIC MEDIA WITH LOW TG BORATES | COVESTRO DEUTSCHLAND AG (DE) | 2018-04-18 | — | — | EP | disclosed |
| US-20160252808-A1 | PHOTOPOLYMER FORMULATION FOR PRODUCTION OF HOLOGRAPHIC MEDIA COMPRISING BORATES WITH LOW TG | COVESTRO DEUTCHLAND AG (DE) | 2016-09-01 | — | — | US | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10001703-B2 | Photopolymer formulation for production of holographic media comprising borates with low TG | PTGIS, TST, MACF1 | CNR1 2460/4885CNR2 1832/4885CA2 647/4885 |
| US-20160252808-A1 | PHOTOPOLYMER FORMULATION FOR PRODUCTION OF HOLOGRAPHIC MEDIA COMPRISING BORATES WITH LOW TG | PTGIS, TST, MACF1 | CNR1 2460/4885CNR2 1832/4885CA2 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.